Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.99% is 130% above its 5-year average of 1.30%, near the high end of its 5-year range (-2.14%–2.99%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.84% above its 12-month average of 2.96%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): 0.69%.
RETURN ON ASSETS (ROA)
2.99%
RETURN ON ASSETS (ROA) AVG TTM
2.96%
RETURN ON ASSETS (ROA) AVG 3Y
2.15%
RETURN ON ASSETS (ROA) AVG 5Y
1.30%
RETURN ON ASSETS (ROA) AVG 10Y
0.92%
RETURN ON ASSETS (ROA) AVG 15Y
2.51%
RETURN ON ASSETS (ROA) AVG 20Y
3.18%
CURRENT VS TTM AVG
+0.84%
CURRENT VS 3Y AVG
+39.39%
CURRENT VS 5Y AVG
+129.71%
CURRENT VS 10Y AVG
+225.32%
CURRENT VS 15Y AVG
+19.35%
CURRENT VS 20Y AVG
-5.89%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-41.83%
vs the sector median at left
Cardinal Health, Inc.
Market Cap
$55.01B
Return on Assets (ROA)
2.99%
TTM Avg
2.96%
3Y Avg
2.15%
5Y Avg
1.30%
Market Cap
$58.20B
Return on Assets (ROA)
-28.75%
TTM Avg
-24.02%
3Y Avg
-10.32%
5Y Avg
-0.33%
Market Cap
$50.40B
Return on Assets (ROA)
1.85%
TTM Avg
3.00%
3Y Avg
3.04%
5Y Avg
2.95%
Market Cap
$49.24B
Return on Assets (ROA)
7.25%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
Market Cap
$63.47B
Return on Assets (ROA)
3.13%
TTM Avg
2.14%
3Y Avg
2.52%
5Y Avg
0.85%
Market Cap
$45.09B
Return on Assets (ROA)
1.77%
TTM Avg
-0.35%
3Y Avg
-1.89%
5Y Avg
-2.43%
Market Cap
$43.73B
Return on Assets (ROA)
4.60%
TTM Avg
4.82%
3Y Avg
4.76%
5Y Avg
4.01%
Market Cap
$66.96B
Return on Assets (ROA)
8.11%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $55.01B | 2.99% | 2.96% | 2.15% | 1.30% |
| Moderna, Inc. (MRNA)vs › | $58.20B | -28.75% | -24.02% | -10.32% | -0.33% |
| Becton, Dickinson and Company (BDX)vs › | $50.40B | 1.85% | 3.00% | 3.04% | 2.95% |
| Edwards Lifesciences Corporation (EW)vs › | $49.24B | 7.25% | 19.91% | 18.29% | 17.04% |
| Humana Inc. (HUM)vs › | $48.93B | 2.23% | 2.52% | 4.20% | 5.49% |
| Cencora, Inc. (COR)vs › | $63.47B | 3.13% | 2.14% | 2.52% | 0.85% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.09B | 1.77% | -0.35% | -1.89% | -2.43% |
| IQVIA Holdings Inc. (IQV)vs › | $43.73B | 4.60% | 4.82% | 4.76% | 4.01% |
| Boston Scientific Corporation (BSX)vs › | $66.96B | 8.11% | 5.66% | 4.50% | 3.49% |
| Agilent Technologies, Inc. (A)vs › | $41.46B | 10.31% | 10.56% | 11.14% | 10.55% |
ROA
3.0%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | 2.99% |
| 2025-06-30 | 2.94% |
| 2024-06-30 | 1.89% |
| 2023-06-30 | 0.76% |
| 2022-06-30 | -2.14% |
| 2021-06-30 | 1.37% |
| 2020-06-30 | -9.06% |
| 2019-06-30 | 3.33% |
| 2018-06-30 | 0.64% |
| 2017-06-30 | 3.21% |
| 2016-06-30 | 4.18% |
| 2015-06-30 | 4.03% |
| 2014-06-30 | 4.48% |
| 2013-06-30 | 1.29% |
| 2012-06-30 | 4.41% |
| 2011-06-30 | 4.20% |
| 2010-06-30 | 3.21% |
| 2009-06-30 | 4.58% |
| 2008-06-30 | 5.55% |
| 2007-06-30 | 8.34% |
| 2006-06-30 | 4.28% |
| 2005-06-30 | 4.76% |
| 2004-06-30 | 6.90% |
| 2003-06-30 | 7.59% |
| 2002-06-30 | 6.43% |
| 2001-06-30 | 5.86% |
| 2000-06-30 | 5.65% |
| 1999-06-30 | 5.43% |
| 1998-06-30 | 3.30% |
| 1997-06-30 | 5.86% |
